British factories should make up AstraZeneca vaccine supply, EU says

Deepening row over vaccines risks bitter EU-UK fallout

‘We have not pulled out’: AstraZeneca will meet EU to discuss vaccine delivery delays

EU Commission had earlier said the pharmaceutical company was refusing to attend

Covid-19: AstraZeneca offers to bring forward EU vaccine delivery to early February

EU asks drugmaker if it can divert doses of vaccine from UK to make up for shortfall

AstraZeneca makes a right mess of vaccine success

Johnson & Johnson vaccine may be game-changer after clumsy missteps by AstraZeneca

European Commission warns AstraZeneca on Covid-19 vaccine delay

Executive says company expects all deliveries to occur as agreed after it warns of delays

Oxford man (82) is first to receive Oxford/AstraZeneca vaccine

Dialysis patient Brian Pinker receives jab as UK rolls out Covid vaccine amid soaring cases

Oxford-AstraZeneca coronavirus vaccine approved for use in UK

UK order 100 million doses of the vaccine - enough to vaccinate 50 million people

AstraZeneca shares fall on ‘hefty’ $39bn Alexion deal

Shares down as much as 9% after weekend announcement

Coronavirus: Australia’s worst-hit region goes 28 days without a case

Almost 61 million cases confirmed worldwide as Japan, New York and Germany see rise

Oxford-AstraZeneca vaccine may be trialled again to prove results were ‘not a mistake’

Drugmaker wants new test to confirm 90% efficacy rate after uncertainty and confusion

Oxford Covid-19 vaccine can be 90% effective, results show

Drug maker AstraZeneca agrees to sell vaccine at cost to developing nations in perpetuity

Growing calls for more transparency on how vaccine trials are run

Researchers say drug companies need to be more open with the public

Oxford Covid trial pause a reminder of huge challenges in race for vaccines

Pharma industry trying to pull off unprecedented feat

AstraZeneca and Gilead explore possibility of merger

Shares dip as it emerges there are no active talks on what would be politically sensitive deal

AstraZeneca targets two billion doses of coronavirus vaccine

Deals involving billionaire Bill Gates guarantee early supply to lower-income countries

AstraZeneca sees years of growth as drug sales turn corner

Drugmaker’s total revenue and earnings fell in the quarter, as analysts had expected

Cancer drug setback knocks 15% off AstraZeneca shares

Results from long-awaited Mystic lung cancer study fail to show hoped-for patient recovery

GlaxoSmithKline abandons plans for new plant in Cumbria

Cantillon: Brexit decision may be giving Big Pharma doubts about British location

Glaxo to pay first woman boss 25% less than male predecessor

Emma Walmsley’s lack of experience cited as justification for salary

AstraZeneca predicts major US healthcare changes under Trump

Pharmaceutical giant reports 4 per cent fall in revenue to $5.7 billion in third quarter

GlaxoSmithKline invests £275m in UK despite Brexit vote

Drugmaker had argued against UK exit from EU over fears about drug regulation

AstraZeneca warns of declining profits in 2016

Arrival of cheap generic rivals to cholesterol drug Crestor expected to affect revenue

AstraZeneca buys 55 per cent stake in Acerta for $4 billion

Deal gives drugmaker a late-stage medicine to treat patients for a range of blood cancers

AstraZeneca pips Actelion to buy ZS Pharma for $2.7 billion

British biopharmaceutical company agrees to buy US biotech company

Earnings slide by 33% at AstraZeneca

UK pharma group pays Actavis initial $600m for branded respiratory business in US and Canada

AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer

Company brings forward filing date for new lung cancer drug

Sanofi fires CEO Chris Viehbacher

Investors say CEO pushed too hard to make the French drugmaker more international

AstraZeneca raises forecasts after seeing off Pfizer

Pharma company’s sales in the second quarter rose 4 per cent to $6.45 billion

Ocado’s long-awaited profit fails to convince bears

Grocery price war take shine off earnings

AstraZeneca to attempt explain Pfizer offer rejection

Pfizer expected to issue statement confirming offer rejection today

AstraZeneca must now deliver on its own promises

British pharma group may have seen off Pfizer but unsettled investors will require delivery on challenging targets it set itself in defence of the assault by US rival as share price falls

Pfizer chief faces hostile grilling on takeover bid

Westminster not happy with Ian Reid’s pledges on takeover of AstraZeneca

Conflicting diagnoses on Pfizer’s bid for AstraZeneca

Everyone from union officials to London’s mayor has an opinion on the offer

Astra Zenec eyes round of sales and spin-offs

Chief executive Pascal Soriot keen to press turnround efforts

AstraZeneca sells British research and development site

Firm to take pretax impairment charges of $275m as part of wider restructuring programme

AstraZeneca forecasts faster return to growth

Drugmaker more confident following $4bn deal to buy Bristol-Myers diabetes venture

AstraZeneca to buy out Bristol diabetes venture

Deal involves Amylin, a US biotech they jointly purchased for $7bn last year

AstraZeneca names Dunoyer as CFO as drug sales and profits drop

Sanofi visited amid China investigations

Ministry of industry and commerce visits office of French pharmaceutical company in Shenyang

AstraZeneca CFO to leave company for BG Group

YOU MAY ALSO LIKE...

The Irish Times ePaper

Stardust

Inquests into the nightclub fire that led to the deaths of 48 people

Common Ground

How does a post-Brexit world shape the identity and relationship of these islands